Voronoi, Inc.
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
310210 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 인천광역시 연수구 송도과학로 32 에스동 18층, 연수구
- Website:
- https://voronoi.io
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Voronoi, Inc. is a clinical-stage biotechnology company specializing in the discovery and development of novel therapeutics, with a primary focus on precision medicine for oncology. The company's expertise lies in creating innovative kinase inhibitors and targeted protein degraders. Voronoi leverages its proprietary drug discovery platform, VORONOMICS™, to rapidly identify and optimize drug candidates. This platform is designed to develop therapies with high selectivity and the ability to penetrate the brain barrier. Its pipeline includes targeted treatments for various cancers, such as non-small cell lung cancer (NSCLC) and HER2-positive solid tumors, aiming to accelerate the delivery of new therapies from design to the clinic.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Voronoi, Inc. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
Automate Your Workflow. Get a real-time feed of all Voronoi, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Voronoi, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
